Home › Congenital Adrenal Hyperplasia › Minnesota
Congenital Adrenal Hyperplasia clinical trials in Minnesota
5 studies for Congenital Adrenal Hyperplasia are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
- University of Minnesota, Minneapolis
RecruitingPhase 2/3
Ages 1 to 17 · All sexes · Updated Sep 30, 2026 · NCT07159841A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
- Crinetics Study Site, Minneapolis
- Crinetics Study Site, Rochester
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 30, 2026 · NCT07144163Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
- Mayo Clinic, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07138274Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
- Neurocrine Clinical Site, Minneapolis
RecruitingPhase 2
3 Months – 47 Months · All sexes · Updated Sep 16, 2026 · NCT07536269Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
- Mayo Clinic, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT07104812From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.